Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 11, 2012
Grant Date -
Aug 27, 2009
app pub date -
Nov 30, 2006
filing date -
Nov 30, 2005
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The subject invention relates to the cloning, expression and isolation of recombinant forms of beta-amyloid protein containing a N-terminal methionine (or one or more amino acids) as well as to methods of using this recombinant protein in the production of therapeutic antibodies, in the identification of therapeutic small molecules, and in the performance of diagnostic assays.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully